Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on AI in Medical Imaging Market 

5.1. COVID-19 Landscape: AI in Medical Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global AI in Medical Imaging Market, By AI Technology

8.1. AI in Medical Imaging Market, by AI Technology, 2023-2032

8.1.1. Deep Learning

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Natural Language Processing (NLP)

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global AI in Medical Imaging Market, By Solution

9.1. AI in Medical Imaging Market, by Solution, 2023-2032

9.1.1. Software Tools/ Platform

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Services

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Integration

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Deployment

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global AI in Medical Imaging Market, By Modality 

10.1. AI in Medical Imaging Market, by Modality, 2023-2032

10.1.1. CT Scan

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. MRI

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. X-rays

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Ultrasound Imaging

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Nuclear Imaging

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global AI in Medical Imaging Market, By Application

11.1. AI in Medical Imaging Market, by Application, 2023-2032

11.1.1. Digital Pathology

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Cardiovascular

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Neurology

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Lung (Respiratory System)

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. Breast (Mammography)

11.1.6.1. Market Revenue and Forecast (2020-2032)

11.1.7. Liver (GI)

11.1.7.1. Market Revenue and Forecast (2020-2032)

11.1.8. Oral Diagnostics

11.1.8.1. Market Revenue and Forecast (2020-2032)

11.1.9. Other

11.1.9.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global AI in Medical Imaging Market, By End Use

12.1. AI in Medical Imaging Market, by End Use, 2023-2032

12.1.1. Hospital and Healthcare Providers

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Patients

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Pharmaceuticals and Biotechnology Companies

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Healthcare Payers

12.1.4.1. Market Revenue and Forecast (2020-2032)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global AI in Medical Imaging Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.1.2. Market Revenue and Forecast, by Solution (2020-2032)

13.1.3. Market Revenue and Forecast, by Modality (2020-2032)

13.1.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Forecast, by End Use (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Solution (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Modality (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End Use (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Solution (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Modality (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End Use (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.2.2. Market Revenue and Forecast, by Solution (2020-2032)

13.2.3. Market Revenue and Forecast, by Modality (2020-2032)

13.2.4. Market Revenue and Forecast, by Application (2020-2032) 

13.2.5. Market Revenue and Forecast, by End Use (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Solution (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Modality (2020-2032)

13.2.7. Market Revenue and Forecast, by Application (2020-2032) 

13.2.8. Market Revenue and Forecast, by End Use (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Solution (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Modality (2020-2032)

13.2.10. Market Revenue and Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Forecast, by End Use (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Solution (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Modality (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Forecast, by End Use (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Solution (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Modality (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Forecast, by End Use (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.3.2. Market Revenue and Forecast, by Solution (2020-2032)

13.3.3. Market Revenue and Forecast, by Modality (2020-2032)

13.3.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Forecast, by End Use (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Solution (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Modality (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Forecast, by End Use (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Solution (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Modality (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Forecast, by End Use (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Solution (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Modality (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End Use (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Solution (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Modality (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End Use (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.4.2. Market Revenue and Forecast, by Solution (2020-2032)

13.4.3. Market Revenue and Forecast, by Modality (2020-2032)

13.4.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Forecast, by End Use (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Solution (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Modality (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Forecast, by End Use (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Solution (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Modality (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Forecast, by End Use (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Solution (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Modality (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End Use (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Solution (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Modality (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End Use (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.5.2. Market Revenue and Forecast, by Solution (2020-2032)

13.5.3. Market Revenue and Forecast, by Modality (2020-2032)

13.5.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Forecast, by End Use (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Solution (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Modality (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Forecast, by End Use (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Solution (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Modality (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End Use (2020-2032)

Chapter 14. Company Profiles

14.1. Agfa-Gevaert Group/Agfa HealthCare

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Arterys

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. AI

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. AZmed

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Butterfly Network

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Caption Health

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. CellmatiQ

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. dentalXrai

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Digital Diagnostics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. EchoNous

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms